282 related articles for article (PubMed ID: 20404023)
1. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
[TBL] [Abstract][Full Text] [Related]
2. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2012 Dec; 135(3):1643-52. PubMed ID: 22953905
[TBL] [Abstract][Full Text] [Related]
4. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
6. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity.
Su SJ; Chow NH; Kung ML; Hung TC; Chang KL
Nutr Cancer; 2003; 45(1):113-23. PubMed ID: 12791511
[TBL] [Abstract][Full Text] [Related]
7. Soy extract has different effects compared with the isolated isoflavones on the proteome of homocysteine-stressed endothelial cells.
Fuchs D; Dirscherl B; Schroot JH; Daniel H; Wenzel U
Mol Nutr Food Res; 2006 Jan; 50(1):58-69. PubMed ID: 16502433
[TBL] [Abstract][Full Text] [Related]
8. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways.
Valachovicova T; Slivova V; Bergman H; Shuherk J; Sliva D
Int J Oncol; 2004 Nov; 25(5):1389-95. PubMed ID: 15492830
[TBL] [Abstract][Full Text] [Related]
9. Genistein and daidzein: different molecular effects on prostate cancer.
Adjakly M; Ngollo M; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
Anticancer Res; 2013 Jan; 33(1):39-44. PubMed ID: 23267126
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
Szliszka E; Krol W
Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
[TBL] [Abstract][Full Text] [Related]
12. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP.
Onozawa M; Fukuda K; Ohtani M; Akaza H; Sugimura T; Wakabayashi K
Jpn J Clin Oncol; 1998 Jun; 28(6):360-3. PubMed ID: 9730149
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines.
Adjakly M; Bosviel R; Rabiau N; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
Epigenomics; 2011 Dec; 3(6):795-803. PubMed ID: 22126297
[TBL] [Abstract][Full Text] [Related]
14. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
[TBL] [Abstract][Full Text] [Related]
16. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.
Singh AV; Franke AA; Blackburn GL; Zhou JR
Cancer Res; 2006 Feb; 66(3):1851-8. PubMed ID: 16452247
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?
Karsli-Ceppioglu S; Ngollo M; Adjakly M; Dagdemir A; Judes G; Lebert A; Boiteux JP; Penault-LLorca F; Bignon YJ; Guy L; Bernard-Gallon D
OMICS; 2015 Apr; 19(4):209-19. PubMed ID: 25831061
[TBL] [Abstract][Full Text] [Related]
18. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
Zhou JR; Yu L; Zhong Y; Nassr RL; Franke AA; Gaston SM; Blackburn GL
Prostate; 2002 Oct; 53(2):143-53. PubMed ID: 12242729
[TBL] [Abstract][Full Text] [Related]
20. Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones.
Ajdžanović V; Mojić M; Maksimović-Ivanić D; Bulatović M; Mijatović S; Milošević V; Spasojević I
J Membr Biol; 2013 Apr; 246(4):307-14. PubMed ID: 23417033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]